HRT Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$126M Buy
2,075,945
+1,876,844
+943% +$109M 0.31% 43
2025
Q4
$10.7M Sell
199,101
-824,150
-81% -$39.6M 0.03% 431
2025
Q3
$46.1M Buy
+1,023,251
New +$47.8M 0.17% 70
2025
Q2
Sell
-704,900
Closed -$43M 2650
2025
Q1
$43M Sell
704,900
-899,981
-56% -$52.5M 0.27% 42
2024
Q4
$90.8M Buy
1,604,881
+1,589,449
+10,300% +$88.8M 0.47% 29
2024
Q3
$798K Buy
+15,432
New +$724K ﹤0.01% 1364
2024
Q1
Sell
-221,739
Closed -$11.4M 2356
2023
Q4
$11.4M Buy
+221,739
New +$11.6M 0.08% 140
2023
Q3
Sell
-229,452
Closed -$14.7M 2424
2023
Q2
$14.7M Buy
+229,452
New +$15.4M 0.14% 101
2023
Q1
Sell
-75,662
Closed -$5.44M 2518
2022
Q4
$5.44M Buy
+75,662
New +$5.71M 0.08% 245
2022
Q3
Sell
-30,539
Closed -$2.35M 2820
2022
Q2
$2.35M Sell
30,539
-279,862
-90% -$21.3M 0.03% 501
2022
Q1
$22.7M Buy
+310,401
New +$20.8M 0.16% 67
2021
Q3
Sell
-303,393
Closed -$20.3M 3294
2021
Q2
$20.3M Buy
303,393
+70,388
+30% +$4.59M 0.19% 86
2021
Q1
$14.7M Buy
233,005
+174,274
+297% +$10.8M 0.15% 84
2020
Q4
$3.64M Buy
+58,731
New +$3.61M 0.07% 198
2020
Q3
Sell
-660,374
Closed -$38.8M 1905
2020
Q2
$38.8M Buy
+660,374
New +$39.5M 1.17% 9
2015
Q1
Sell
-3,765
Closed -$222K 70
2014
Q4
$222K Buy
+3,765
New +$212K 0.31% 48

Other funds holding BMY

HRT Financial's BMY Position: Q1 2026 in Review

HRT Financial increased its Bristol-Myers Squibb (BMY) stake by 943% in Q1 2026, buying an estimated $109M and bringing the position to 2,075,945 shares worth $126M. The position accounts for 0.31% of the portfolio, ranked #43.

HRT Financial first reported a position in BMY in Q4 2014 and has held it in 16 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • HRT Financial held 2,075,945 shares of Bristol-Myers Squibb worth $126M as of Q1 2026.
  • HRT Financial bought 1,876,844 Bristol-Myers Squibb shares in Q1 2026, an estimated $109M.
  • Bristol-Myers Squibb made up 0.31% of HRT Financial's portfolio in Q1 2026, its #43 holding.
  • HRT Financial first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 16 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.